Sky Labs Forms Strategic Partnership with OMRON Ventures
Sky Labs has recently announced a significant investment partnership with OMRON Ventures, an extension of the OMRON Group, which is known for revolutionizing healthcare technology. This strategic collaboration is designed to bolster Sky Labs' goals in expanding its global business through advanced technology and healthcare solutions.
Innovative MoU to Advance Global Presence
In a move aimed at strengthening collaboration, Sky Labs has signed a Memorandum of Understanding (MoU) with OMRON Healthcare, a leader in the global blood pressure monitoring market. This agreement is pivotal as it emphasizes developing their partnership to foster innovation and open new avenues for growth in healthcare.
Transformative Developments in Health Monitoring
Key to this partnership is Sky Labs' innovative product, the "CART BP," a cuffless and ring-shaped blood pressure monitoring device that has been touted as the first of its kind in the world. This device allows for continuous monitoring of blood pressure throughout a user's daily routine, even during sleep, significantly enhancing the ability to prevent chronic diseases.
The unique feature of the "CART BP" is its capability to continuously measure blood pressure metrics over the day and night, providing users with valuable data to track health trends and detect issues earlier. As healthcare evolves, having real-time access to such data can dramatically influence early preventive measures against hypertension and cardiovascular diseases.
OMRON Healthcare: A Leader in Medical Solutions
OMRON Healthcare has established itself as the number one entity in the medical device sector, distributing blood pressure monitors and cardiovascular health solutions to more than 130 countries. In recent years, the company has surpassed cumulative sales of over 400 million units of blood pressure monitoring devices, fully reflecting its commitment to innovative healthcare solutions.
The Vision of Sky Labs CEO
Jack Byunghwan Lee, the CEO of Sky Labs, highlighted that this partnership stands as recognition of Sky Labs' technological advancements and clinical efficacy. He expressed confidence that together with OMRON Healthcare, they will lead a transformative wave in the healthcare industry, targeting chronic disease management and promoting better accessibility to health monitoring technologies.
About Sky Labs
Founded in September 2015, Sky Labs has rapidly ascended in the healthcare technology arena with innovations aimed at enhancing life quality through insightful health monitoring. Their cornerstone product, the "CART BP," is engineered for around-the-clock blood pressure tracking, providing essential information that can alter treatment strategies and patient quality of life.
Sky Labs has secured an exclusive distribution agreement for its products with Daewoong Pharmaceutical in South Korea, propelling plans for distribution to hospitals, clinics, and consumers nationwide.
Frequently Asked Questions
What is the focus of the partnership between Sky Labs and OMRON Ventures?
The partnership aims to enhance global business growth through technologically advanced healthcare solutions, particularly in blood pressure monitoring.
What is the "CART BP" device?
The "CART BP" is a cuffless, ring-shaped blood pressure monitor developed by Sky Labs, allowing users to track their blood pressure continuously in a non-invasive manner.
How does the "CART BP" improve healthcare?
The device enables around-the-clock monitoring and tracking of blood pressure changes, which can assist in the early detection and prevention of chronic diseases.
What is OMRON Healthcare's role in the medical device industry?
OMRON Healthcare is a leading manufacturer of medical devices related to cardiovascular health, with a significant global reach and over 400 million units sold.
How does Sky Labs plan to expand its market presence?
Sky Labs plans to expand its market presence by leveraging strategic partnerships and innovative products like the "CART BP" to reach more healthcare providers and consumers.
